NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Paul Beavis
AD Scientific Index 2024
Others
Peter Maccallum Cancer Centre - - / Australia
-
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Paul Beavis's MOST POPULAR ARTICLES
1-)
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosisP Savas, B Virassamy, C Ye, A Salim, CP Mintoff, F Caramia, R Salgado, ...Nature medicine 24 (7), 986-993, 20187402018
2-)
Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cellsLB John, C Devaud, CPM Duong, CS Yong, PA Beavis, NM Haynes, ...Clinical cancer research 19 (20), 5636-5646, 20137322013
3-)
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunityML Burr, CE Sparbier, YC Chan, JC Williamson, K Woods, PA Beavis, ...Nature 549 (7670), 101-105, 20175262017
4-)
RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune …S Loi, S Dushyanthen, PA Beavis, R Salgado, C Denkert, P Savas, ...Clinical Cancer Research 22 (6), 1499-1509, 20165382016
5-)
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancerS Loi, S Pommey, B Haibe-Kains, PA Beavis, PK Darcy, MJ Smyth, ...Proceedings of the National Academy of Sciences 110 (27), 11091-11096, 20135332013
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept